Evidence of Relationships Between cabergoline and Heart Valve Diseases

From Publications

Relationship	Evidence	Details
CO PK	Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med. 2007. Zanettini Renzo, et al. PMID: 17202454.	View
PK	Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med. 2007. Schade René, et al. PMID: 17202453.	View

Feedback
Sitemap
Privacy Policy
Usage Conditions
Acknowledgements
Citing PharmGKB

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (GM61374).
©2001-2010 PharmGKB.